Adimmune Corporation (TPE:4142)
Taiwan · Delayed Price · Currency is TWD 19.70
-0.10 (-0.51%)
Jan 22, 2026, 11:44 AM CST
Adimmune Market Cap
Adimmune has a market cap or net worth of 8.35 billion as of January 21, 2026. Its market cap has decreased by -0.50% in one year.
Market Cap
8.35B
Enterprise Value
9.96B
Revenue
1.20B
Ranking
n/a
PE Ratio
n/a
Stock Price
19.70
Market Cap Chart
Since September 29, 2010, Adimmune's market cap has decreased from 11.10B to 8.35B, a decrease of -24.80%. That is a compound annual growth rate of -1.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 8.35B | 4.49% |
| Dec 31, 2025 | 7.99B | -5.72% |
| Dec 31, 2024 | 8.47B | -39.37% |
| Dec 29, 2023 | 13.97B | -7.97% |
| Dec 30, 2022 | 15.18B | -20.83% |
| Dec 30, 2021 | 19.18B | -20.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 10.84B |
| TaiGen Biopharmaceuticals Holdings | 10.00B |
| PharmaEngine | 10.00B |
| Gongwin Biopharm Holdings | 9.55B |
| Acepodia | 8.38B |
| Mycenax Biotech | 7.15B |
| OBI Pharma | 6.65B |
| Savior Lifetec | 6.27B |